Philip Raskin
University of Texas Southwest Medical Center
Dallas 75390
USA
Name/email consistency: high
- Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Raskin, P., Bode, B.W., Marks, J.B., Hirsch, I.B., Weinstein, R.L., McGill, J.B., Peterson, G.E., Mudaliar, S.R., Reinhardt, R.R. Diabetes. Care (2003)
- A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes. Raskin, P., Rendell, M., Riddle, M.C., Dole, J.F., Freed, M.I., Rosenstock, J. Diabetes. Care (2001)
- Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes. Raskin, P., Jovanovic, L., Berger, S., Schwartz, S., Woo, V., Ratner, R. Diabetes. Care (2000)